First published 13 November 2016 · revised August 2026. The original argued from what I had seen in clinic. Research published since has measured it.
Your time is limited, so don’t waste it living someone else’s life. Don’t be trapped by dogma — which is living with the results of other people’s thinking. Don’t let the noise of others’ opinions drown out your own inner voice. […] Stay Hungry. Stay Foolish.
— Steve Jobs, Stanford commencement address, 2005
By the time he gave that speech he had already had surgery for a pancreatic neuroendocrine tumour, and had said it saved his life. What he did not say was that for roughly nine months after the diagnosis he declined that surgery, against the advice of his physicians, his friends and his family, and tried a range of alternative approaches instead.
Let me say at the outset that I admire Jobs as a creative figure and an entrepreneur, that I have never seen his medical records, and that everything I know about his illness comes from Walter Isaacson’s authorised biography and Jobs’s own public statements. I am not trying to pass judgement on a dying man’s choices. I write about the case because it illustrates, unusually clearly and in public, a pattern I have watched repeat in ordinary consulting rooms for twenty years.
An important distinction most coverage got wrong
Jobs did not have pancreatic cancer in the sense most people mean. He had a pancreatic neuroendocrine tumour — an islet cell tumour — not pancreatic adenocarcinoma.
The difference is not academic. Adenocarcinoma is among the most lethal cancers in medicine, and by the time it is found, little can usually be done. Neuroendocrine tumours typically grow slowly and carry vastly better survival, particularly when removed early.
That is exactly why the delay was significant. He had the kind of pancreatic tumour where time is on your side — and time was the thing he spent.
How could a man that intelligent make that decision?
I do not think he was stupid, and I do not think he was in simple denial. He was extraordinarily clever, and he had good advice from every direction. Which is the point. Intelligence is not protective here. If anything, the people I have found hardest to reach are those most accustomed to reasoning their way past received opinion — because that habit has served them brilliantly everywhere else.
Five mistakes, and why they recur
These frame a pattern of reaction I see repeatedly in patients drawn to “natural” treatment when a frightening diagnosis lands.
1. Magical thinking
Isaacson, describing Jobs’s response to the diagnosis, put it this way:
I think that he kind of felt that if you ignore something, if you don’t want something to exist, you can have magical thinking…
— Walter Isaacson, on Steve Jobs
This was Jobs’s own cast of mind — the same refusal to accept given constraints that colleagues called his reality distortion field, and which had genuinely produced remarkable things at Apple. Applied to a tumour, it did not work. It has not worked for anyone.
2. Not wanting the body “violated”
I didn’t want my body to be opened… I didn’t want to be violated in that way.
— Steve Jobs, quoted in Isaacson
This is not the same as ordinary fear of the knife, and I have heard versions of it many times. There is a deep intuition that the body is whole and that cutting it is a form of harm — which, viewed narrowly, it is. Surgery is controlled injury. The difficulty is that the alternative on offer was not wholeness; it was a tumour left in place.
3. Natural first, conventional later
I hear this constantly, and I have sympathy with the impulse behind it. Doctors are frequently too rushed to discuss diet, exercise, sleep or stress. Some are genuinely ignorant of them and reach for the prescription pad by default. That is a real failing and I have written about it elsewhere.
But look at the actual standard of care for chronic disease — hypertension, dyslipidaemia, type 2 diabetes — and therapeutic lifestyle change sits at the front of every guideline, ahead of medication. The dichotomy is largely imagined.
Two further points. Everything on earth is chemical, including every herb ever brewed; “natural” and “chemical” is not a real distinction. And more importantly, lifestyle measures are powerful at preventing disease and much weaker at reversing it once established. Relying on diet and herbs to cure an existing cancer is like hoping that driving under the speed limit will fix a leaking radiator.
4. Preferring alternative medicine to treatment that works
There are no good studies showing cure of islet cell pancreatic cancer by alternative medicine. That is not a claim that everything under the alternative heading is worthless — some of it is ordinary good advice wearing an unusual hat.
What bothers me is the substitution. I see it constantly with blood pressure: “Let me try this supplement for a while, doc, and if it doesn’t work, I’ll do what you said.” The trial period is rarely free.
What has been measured since I first wrote this
In 2016 I argued this from clinical impression. There is now data.
- Among patients with non-metastatic breast, prostate, lung or colorectal cancer, those who chose alternative medicine instead of conventional treatment had about 2.5 times the risk of death. Five-year survival was 54.7% against 78.3%.1
- A companion study found that patients using complementary medicine alongside conventional care were more likely to refuse some component of that care — and it was the refusal, not the complementary medicine itself, that predicted worse survival.2
That second finding is the more useful one, and it is more sympathetic than it first appears. The danger is not the herbal tea. It is what the herbal tea gives you permission to decline.
5. Disregarding “dogma”
Don’t be trapped by dogma — which is living with the results of other people’s thinking.
Excellent advice for finding your purpose, or for breaking the assumptions that keep an industry stuck. Considerably worse advice for treating a tumour.
We live in an age where it is neither practical nor possible to break new ground at every turn. We rely on other people’s thinking constantly, and rightly. Would you rather spend years in a laboratory reinventing the light bulb, or flip the switch? Knowing when to overturn the consensus and when to accept it is most of what wisdom consists of — and a diagnosis is a poor place to practise the former.
What I am not saying
That he would have lived had he operated sooner. Nobody can know that. Neuroendocrine tumours vary widely in aggressiveness, and it is entirely possible the outcome would have been the same. One case establishes nothing.
That patients who choose otherwise are foolish. Almost everyone who takes this path is frightened, and is trying to keep hold of some control in a situation that has taken all of it away. That is a human response, not a stupid one.
And I am not saying doctors are blameless. The reason “natural first” is so appealing is partly that conventional medicine often communicates badly, rushes people, and neglects exactly the lifestyle factors that would have helped. We built some of this ourselves.
What I am saying is narrower: when a treatable cancer is present, the cost of the trial period is measured in survival, and it has now been counted.
References
The 2016 original argued from clinical experience alone. These are the studies that have since quantified it.
- Johnson SB, Park HS, Gross CP, Yu JB. Use of alternative medicine for cancer and its impact on survival. JNCI: Journal of the National Cancer Institute. 2018;110(1):121–124. https://doi.org/10.1093/jnci/djx145 Used for the 2.5-fold mortality risk and five-year survival of 54.7% against 78.3%.
- Johnson SB, Park HS, Gross CP, Yu JB. Complementary medicine, refusal of conventional cancer therapy, and survival among patients with curable cancers. JAMA Oncology. 2018;4(10):1375–1381. https://doi.org/10.1001/jamaoncol.2018.2487 Used for the finding that refusal of conventional treatment, rather than complementary medicine itself, drove the survival difference.
- Isaacson W. Steve Jobs. New York: Simon & Schuster; 2011. Source of the quoted material and of the account of the nine-month delay.